Skip to content
Subscriber Only

Biopharma Outsourcing Is Going Through Deal Bonanza in U.S.

  • M&A in the first half already tops annual volumes of 2007-15
  • More deals are likely in coming months: William Blair analyst
Photographer: Photographer: Nicky Loh/Bloomberg

For the little-known companies doing the grunt work of drugmakers, it’s deal season.

Contract research organizations -- the science-for-hire firms that handle clinical trials, medical-lab testing and other services for pharmaceutical companies -- are all the talk of the health-care M&A world. The latest transaction was the $4.5 billion takeout of Parexel International Corp. on Tuesday. And analysts say there’s more to come.